203 related articles for article (PubMed ID: 32502142)
1. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
[TBL] [Abstract][Full Text] [Related]
3. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
4. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer.
Liu S; Wang W; Ning Y; Zheng H; Zhan Y; Wang H; Yang Y; Luo J; Wen Q; Zang H; Peng J; Ma J; Fan S
Cell Death Dis; 2022 Feb; 13(2):129. PubMed ID: 35136028
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
[TBL] [Abstract][Full Text] [Related]
8. Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
Han L; Zhang G; Zhang N; Li H; Liu Y; Fu A; Zheng Y
Med Oncol; 2014 Sep; 31(9):129. PubMed ID: 25064732
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
Han B; Zhang Q; Li G; Zhang R; Li H
Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
14. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
16. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
[TBL] [Abstract][Full Text] [Related]
17. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
18. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.
Yoshizawa A; Fukuoka J; Shimizu S; Shilo K; Franks TJ; Hewitt SM; Fujii T; Cordon-Cardo C; Jen J; Travis WD
Clin Cancer Res; 2010 Jan; 16(1):240-8. PubMed ID: 20008839
[TBL] [Abstract][Full Text] [Related]
20. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
Wang H; Wang J; Liang CF; Zhou T
Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]